Cargando…

Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects. They present with a myriad of systemic features and require potent immunosuppression. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Auanassova, Akerke, Yessirkepov, Marlen, Zimba, Olena, Gasparyan, Armen Yuri, Joshi, Mrudula, Agarwal, Vikas, Kitas, George D., Ahmed, Sakir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684751/
https://www.ncbi.nlm.nih.gov/pubmed/36414862
http://dx.doi.org/10.1007/s10067-022-06452-0
_version_ 1784835361943322624
author Auanassova, Akerke
Yessirkepov, Marlen
Zimba, Olena
Gasparyan, Armen Yuri
Joshi, Mrudula
Agarwal, Vikas
Kitas, George D.
Ahmed, Sakir
author_facet Auanassova, Akerke
Yessirkepov, Marlen
Zimba, Olena
Gasparyan, Armen Yuri
Joshi, Mrudula
Agarwal, Vikas
Kitas, George D.
Ahmed, Sakir
author_sort Auanassova, Akerke
collection PubMed
description Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects. They present with a myriad of systemic features and require potent immunosuppression. Since they are uncommonly encountered in clinical practice, it is necessary to understand physicians’ knowledge and perceptions about this group of diseases. An online questionnaire was designed featuring 28 questions based on relevant global practice guidelines, recommendations, and previous online surveys on AAV. The questionnaire was validated by a core group of specialists with an interest in AAV. It was shared via social networking sites and entries were restricted to physicians. Only completed entries were analyzed with descriptive statistics. A total of 113 respondents from 21 different countries responded of whom the commonest were rheumatologists, internists, and general practitioners. Forty-five (40%) ran clinics dedicated to AAV patients as a part of their practice. They commented on organs involved in AAV; vasculitis secondary to infections, drugs or other rheumatic diseases; various tests useful for AAV diagnosis; and drug choices for induction and maintenance. They mentioned their experience regarding COVID-19 in AAV patients as well as vasculitic manifestations of COVID-19. Various methods to mitigate cardiovascular risks in AAV were mentioned. Finally, the respondents indicated how medical education needed to be strengthened to increase awareness and knowledge regarding AAV. This survey helped to inform about various perceptions regarding AAV across countries, including current practices and recent evolution of management. It also provided information on treatment of the COVID-19 in AAV patients. This survey showed that there is still a lack in understanding the prevalent definitions and there is gap between guidelines and current practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-022-06452-0.
format Online
Article
Text
id pubmed-9684751
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-96847512022-11-28 Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic Auanassova, Akerke Yessirkepov, Marlen Zimba, Olena Gasparyan, Armen Yuri Joshi, Mrudula Agarwal, Vikas Kitas, George D. Ahmed, Sakir Clin Rheumatol Brief Report Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by necrotizing inflammation of small and medium-size vessels that often manifest with devastating multi-organ effects. They present with a myriad of systemic features and require potent immunosuppression. Since they are uncommonly encountered in clinical practice, it is necessary to understand physicians’ knowledge and perceptions about this group of diseases. An online questionnaire was designed featuring 28 questions based on relevant global practice guidelines, recommendations, and previous online surveys on AAV. The questionnaire was validated by a core group of specialists with an interest in AAV. It was shared via social networking sites and entries were restricted to physicians. Only completed entries were analyzed with descriptive statistics. A total of 113 respondents from 21 different countries responded of whom the commonest were rheumatologists, internists, and general practitioners. Forty-five (40%) ran clinics dedicated to AAV patients as a part of their practice. They commented on organs involved in AAV; vasculitis secondary to infections, drugs or other rheumatic diseases; various tests useful for AAV diagnosis; and drug choices for induction and maintenance. They mentioned their experience regarding COVID-19 in AAV patients as well as vasculitic manifestations of COVID-19. Various methods to mitigate cardiovascular risks in AAV were mentioned. Finally, the respondents indicated how medical education needed to be strengthened to increase awareness and knowledge regarding AAV. This survey helped to inform about various perceptions regarding AAV across countries, including current practices and recent evolution of management. It also provided information on treatment of the COVID-19 in AAV patients. This survey showed that there is still a lack in understanding the prevalent definitions and there is gap between guidelines and current practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10067-022-06452-0. Springer International Publishing 2022-11-21 2023 /pmc/articles/PMC9684751/ /pubmed/36414862 http://dx.doi.org/10.1007/s10067-022-06452-0 Text en © The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Brief Report
Auanassova, Akerke
Yessirkepov, Marlen
Zimba, Olena
Gasparyan, Armen Yuri
Joshi, Mrudula
Agarwal, Vikas
Kitas, George D.
Ahmed, Sakir
Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title_full Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title_fullStr Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title_full_unstemmed Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title_short Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic
title_sort physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the covid-19 pandemic
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684751/
https://www.ncbi.nlm.nih.gov/pubmed/36414862
http://dx.doi.org/10.1007/s10067-022-06452-0
work_keys_str_mv AT auanassovaakerke physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT yessirkepovmarlen physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT zimbaolena physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT gasparyanarmenyuri physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT joshimrudula physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT agarwalvikas physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT kitasgeorged physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic
AT ahmedsakir physiciansperceptionsaboutantineutrophilcytoplasmicantibodyassociatedvasculitisanonlinesurveyreportinthetimeofthecovid19pandemic